Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Ceralasertib and olaparib
Study Title: This study was done to learn how
ceralasertib with olaparib
worked in participants with
extensive-stage small-cell
lung cancer
Protocol Number: D419QC00002
Thank you
Thank you to the participants who took part in the clinical study for the study
drugs ceralasertib and olaparib.
All of the participants helped researchers learn more about ceralasertib with
olaparib to help people with extensive-stage small-cell lung cancer, also called ES-
SCLC.
AstraZeneca AB sponsored this study and believes it is important to share the
results of the study with the participants and the public. An independent non-profit
organization called CISCRP helped prepare this summary of the study results. We
hope it helps the participants understand and feel proud of their important role in
medical research.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1